Skip to main content

Table 3 Descriptive and comparative statistics of routine laboratory tests between different genotypes among T2DM patients using Wilcoxon rank sum test

From: Study of the association between GLIS3 rs10758593 and type 2 diabetes mellitus in Egyptian population

Ā 

Patients (T2DM) (nā€‰=ā€‰100)

Ā 

AA (nā€‰=ā€‰39)

AG (nā€‰=ā€‰61)

z value

p value

Sig.

Age (years)

Median (IQR)

53 (46ā€“58)

51 (46ā€“58)

āˆ’ā€‰0.134

0.893

NS

BMI

Median (IQR)

29 (27.1ā€“31)

29 (27ā€“31)

āˆ’ā€‰0.361

0.718

NS

HbA1C (%)

Median (IQR)

9.1 (7.4ā€“10.6)

7.7 (7.0ā€“8.8)

āˆ’ā€‰2.588

0.01

S

Fasting blood glucose (mg/dL)

Median (IQR)

223 (168ā€“29 8)

175 (130ā€“217)

āˆ’ā€‰3.032

0.002

S

Fasting insulin(mIU/L)

Median (IQR)

18 (16ā€“24)

13 (11ā€“17)

āˆ’ā€‰4.641

<ā€‰0.001

HS

HOMA-IR

Median (IQR)

10.49 (8.69ā€“13.14)

5.84 (4.16ā€“7.95)

āˆ’ā€‰5.307

<ā€‰0.001

HS

  1. IQR interquartile range, p value probability, BMI body mass index, T2DM type 2 diabetes mellitus, HbA1C glycated hemoglobin, HOMA-IR homeostatic model assessment for insulin resistance, n number, NS non-significant, S Significant, HS highly significant